A non-myeloablative regimen with minimal non relapse mortality for allografting patients with Hodgkin's disease

被引：0
|
作者：
Kottaridis, P
Milligan, D
Chopra, R
Craddock, C
Mahendra, P
Hunter, A
Marsh, J
Chakraverty, R
Mills, A
Kyriakou, C
McKeag, N
Hale, G
Waldmann, H
Linch, D
Goldstone, A
Mackinnon, S
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [41] Non-myeloablative conditioning and peripheral blood stem cell (PBSC) allografting for poor prognosis patients (pts) with hematological malignancies.
    Hansz, J
    Gozdzik, J
    Gil, L
    Drozdowska, D
    Sawinski, K
    Kozlowska-Skrzypczak, M
    BLOOD, 2000, 96 (11) : 355B - 355B
  • [42] Allogeneic CD4+ lymphocytes play a major role to achieve the engraftment of donor cells after allografting with non-myeloablative conditioning regimen.
    Corsetti, MT
    Pira, GL
    Manca, F
    Carella, AM
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 69 - 69
  • [43] Allogenic PBSC transplantation after non-myeloablative regimen containing busulfan, fludarabine, and ATG
    Mayer, J
    Krahulova, M
    Koristek, Z
    Dvorakova, D
    Brychtova, Y
    Doubek, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S289 - S290
  • [44] Unrelated cord blood transplantation with non-myeloablative conditioning regimen in paediatric acute leukaemia
    Ahn, HS
    Kang, HJ
    Park, ES
    Choi, HS
    Shin, HY
    BONE MARROW TRANSPLANTATION, 2005, 35 : S365 - S365
  • [45] MIXED ALLOGENEIC CHIMERAS PREPARED BY A NON-MYELOABLATIVE REGIMEN - REQUIREMENT FOR CHIMERISM TO MAINTAIN TOLERANCE
    SHARABI, Y
    ABRAHAM, VS
    SYKES, M
    SACHS, DH
    BONE MARROW TRANSPLANTATION, 1992, 9 (03) : 191 - 197
  • [46] Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
    Mackinnon, S
    Kottaridis, P
    Perry, A
    Chakrabarti, S
    Milligan, DW
    Pettengell, R
    Chopra, R
    Morgan, G
    Hale, G
    Waldmann, H
    Linch, DC
    Devereux, S
    Goldstone, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 31 - 31
  • [47] Improvement of matched sibling donor engraftment with sirolimus added to a non-myeloablative conditioning regimen
    Claxton, DF
    Ehmann, C
    Shaffer, M
    Rybka, W
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 25 - 25
  • [48] Radioimmunotherapy (RAIT) with 131I labeled rituximab in patients with B-cell NHL in a myeloablative and non-myeloablative regimen.
    Schmidt, B
    Scheidhauer, K
    Schwaiger, M
    Peschel, C
    von Schilling, C
    BLOOD, 2000, 96 (11) : 247B - 247B
  • [49] Allogeneic engraftment of mismatched unrelated cord blood following a non-myeloablative preparative regimen
    Chao, NJ
    Rizzieri, DA
    Long, GD
    Vredenburgh, JJ
    Gasparetto, C
    Morris, A
    Davis, P
    LEUKEMIA, 2002, 16 (03) : 407 - 407
  • [50] New non-myeloablative conditioning regimen for multiple sclerosis patients undergoing autologous hematopoietic stem cell transplantation
    Novik, Andrei A.
    Kuznetsov, Alexey N.
    Melnichenko, Vladimir Y.
    Fedorenko, Denis A.
    Ionova, Tatiana L.
    Kruglina, Ruslana V.
    Kartashov, Andrei V.
    Gorodokin, Gary J.
    MULTIPLE SCLEROSIS, 2008, 14 : S169 - S169
12345